Breaking NFL Confirms Ineligibility for Players Returning to College Meta Reaches Up To $18 Billion Settlement Over Lawsuit Alleging Addictive Platform Design Affecting Children Eight Dead in Billings Home Fire, Authorities Investigate as Homicide LIV Golf Announces Staff Reductions Amidst Shift from Saudi Funding Dolly Parton’s Life and Career Featured in Visual Retrospective

Wednesday August 26, 2026

Reporter

Immuneering Corporation

3Articles Published

5Communities Covered

Published Articles

Press Release

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

2 hours ago

Press Release

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Aug 5

Press Release

Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition

Jul 21